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ABSTRACT
This article is written to document the research conducted by student Brady Fritz and mentor Dr. Norma
Ortiz-Robinson during the 2019 Student Summer Scholars Program at Grand Valley State University. The mathemati-
cal model used was developed by Dr. Ami Radunskaya and Dr. Sarah Hook, and it describes the population of certain
groups of cells over time after administration of a certain cancer vaccine. The model was programmed into specialized
software that evaluates the optimal control of the vaccine given specified control parameters. The output was then ana-
lyzed to properly describe the solution obtained.
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INTRODUCTION
In 2012, Dr. Sarah Hook and Dr. Ami Radunskaya created a mathematical model to describe certain groups of cell
populations given a certain cancer vaccine, and documented their finding in their article Modeling the Kinetics of the Im-
mune Response 1. Through the use of genetic algorithms, they found the most optimal time to give a booster shot after
the initial injection in order to maximize the total population of cancer fighting cells to be 3 days.
The goal of our research was to use mathematical theory, namely optimal control theory, to find evidence supporting
or disproving this optimal time for a booster shot. In order to do this, a program written in part by Dr. John Betts
was used to approximate solutions. This program is the Sparse Optimization Suite, which is a good fit for our model
since it can handle time delays which our model includes.
Input for this program is written in the FORTRAN programming language, and its output is generated as a text file
thousands of lines long. After parsing this information, we can find the Sparse Optimization Suite’s optimal solution
for antigen over time, with sharp increases indicating the injection of a booster shot. Required input includes a perfor-
mance index equation, differential equations representing the population of each cell group with respect to time, initial
parameters, and more parameters describing information about the differential system.
As we were never able to receive some of the initial parameters from a collaborating biologist, educated assumptions on
initial cell group populations were made. Our results in the concluding solutions are preliminary. Due to the modular
nature of the input program written, adding in initial parameters once these parameters are received will be expedited.
DIFFERENTIAL SYSTEM RELATING TO CELL POPULATIONS
Each group of cells has their own differential equation describing the rate of increase of its population with respect to
time.
An important biological aspect of this problem is cell flow, or cells from one population becoming cells of another
population. An overall view of the cell flow for this problem is given in Figure 1.
Figure 1. Cell Flow Diagram
Within Figure 1, boxes represent cell populations, arrows represent normal cell flow, and dashed arrows represent cell
flows with associated time delays. Each time delay is the rate of time at which the co-stimulatory APC cell synaptic
allows cells from the base of the arrow to flow to cells of the tip of the arrow. These time delays are listed in Table 1,
along with other model parameters. It is these time delays that made using the Sparse Optimization Suite required to
find the optimal solution, as including time delays in an optimal control problem complicates the solution process.
The cell group populations within the mathematical model are:
A(t) = Antigen PresentingCells
P(t) = Rapidly ProliferatingT-cells
N(t) = NaiveT-cells
M(t) = MemoryCells
B(t) = ActivatedCirculatingCells
The complete system of differential equations is given here:
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And model parameters are given in Table 1. Model parameters, along with the mathematical model for cell popula-
tions, came from Modeling the Kinetics of the Immune Response 1.
Table 1. Model Parameters
Name CD4 T-Cell Value Units Description
µBS 0.4907 Transfer rate of T-cells from Blood to Spleen
µSB 0.012 Reduced Transfer rate of T-cells from Spleen to Blood
µD 1* Decay rate of the Antigen in the Blood
τ 0.5 d Co-stimulatory APC-Proliferating T-cell Synaptic
Time
τN 0.45 d Co-stimulatory APC-Naive T-cell Synaptic Time
τM 0.01 d Co-stimulatory APC-Memory T-cell Synaptic Time
∆ 10.00 Maximum reduction of rate of transfer of T-cells
from Spleen to Blood
δA 0.17 d−1 Proliferating T-cell Apoptosis rate
δD 0.2370 d−1 Per cell death rate of APC’s
δN 1.3 d−1 Per cell death rate of Naive T-cells
δT 0.3 d−1 Per cell death rate of Activated T-cells in the "basic"
state
θ 1300 cells Number of APC’s necessary to stimulate half the
MA Proliferation rate
w 0.36 d−1 Activation rate of Memory cells by APC’s
r 0.13 Rate of Production of new Memory cells from Acti-
vated T-Cells
g 0.9* Not originally defined
T 1.6 d Average duration of Rapid Expansion Phase
ρ 4842 d−1 Maximum T-cell Proliferation rate
PL 0* Pulse Length
* = Value was not originally given by Dr. Radunskaya and Dr. Hook in their article
PERFORMANCE INDEX
The performance index of an optimal control problem is an equation that defines what we seek to optimize in context
of the problem. The performance index we chose is defined as follows:
(P ′) max
u
aM(T )− b
∫ T
0
u2(t) dt
Our aim is to define optimization as reaching the maximum amount of memory cells while also minimizing the amount
of vaccine administered. The reasoning behind this decision is that by maximizing the amount of memory cells, the pa-
tient’s body is better able to fight off the cancer. The decision to minimize vaccine has an abundance of positive effects.
The vaccine used could be costly, and by minimizing the amount administered, more money is saved. The vaccine
could also have detrimental side effects to the patient’s overall health, and using less of the vaccine will curtail these
effects. Coefficients a and b are weights attributed to their respective functions, and both were set to 1 during the re-
ported output of this article.
RESULTS
The Sparse Optimization Suite, when given the differential equations, performance index, and initialization of the dif-
ferent cell group populations outputted the data that was turned into these graphs:
Figure 2. CD4 Populations and Control
The control graph which represents vaccine within the body is notable, as it suggests a booster shot should be admin-
istered around 1.5 days into the treatment. This is somewhat different to what Dr. Radunskaya and Dr. Hook found
using genetic algorithms, as they found that a booster should should be administered approximately 3 days into the
treatment. However, since the data used makes assumptions on initial cell populations and also does not include an
equation for highly apoptotic cells these results cannot be considered completely accurate. It is possible that with these
changes the output would be closer to the 3 days Dr. Radunskaya and Dr. Hook predicted, or possibly even further
away. Without this information represented in the optimal control problem, the accuracy of these specific results can-
not be determined.
CONCLUSIONS
Due to the preliminary nature of our research, it cannot be said with full confidence that the optimal time of injection
for booster shot would be around 1.5 days. For this research to conclude at a confident answer, proper initial parame-
ters would need to be obtained from a biologist for the output to be as accurate as possible. As mentioned earlier, the
implementation of this new data would be expedited, as the code written for the Sparse Optimization Suite is modular.
DISSEMINATION
This research has already been disseminated at the Mathematical Association of America’s "Mathfest" of 2019 held in
Cincinnati, OH on August 2nd. This research also was disseminated at the Summer Scholars Showcase as a poster.
Lastly, this manuscript will be submitted to Grand Valley State University’s Institutional Repository, Scholar Works.
There is currently no plan for further dissemination, outside of Student Scholars Day at Grand Valley State University
on April 10th, 2019.
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